Epigenetic Signature Can Predict Inherited, Non-inherited Forms of Breast Cancer | GenomeWeb

NEW YORK (GenomeWeb) – Researchers from University College London reported in Genome Medicine this week that a DNA methylation signature they've uncovered could predict the risk of a woman developing breast cancer.

Although they developed the signature by examining the blood of women who are BRCA1 carriers, it appeared to also be able to predict risk of non-hereditary breast cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.